https://pmc.ncbi.nlm.nih.gov/articles/PMC8107031/
Recombinant human adenovirus type 5 (Oncorine) reverses resistance to immune checkpoint inhibitor...
Immune checkpoint inhibitors (ICIs) have shown significant efficacy in various solid tumors, but only a small subgroup of patients benefit from them because of...